Genomictree Inc.
228760
Kedudukan dalam Saham
#18739
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Harga Saham
$7.00
Modal Pasaran
$171.81M
Perubahan (1 hari)
6.44%
Perubahan (1 tahun)
-47.27%
Negara
KR
Perdagangan Genomictree Inc. (228760)
Kategori
Healthcare
Sejarah harga saham bagi Genomictree Inc. (228760)
Harga penutupan tertinggi: $7.30 pada 2026-10-01
Harga penutupan terendah: $3.98 pada 2017-04-01
Harga penutupan terendah: $3.98 pada 2017-04-01
Sejarah harga saham Genomictree Inc. dari 2017 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -34.69% |
| 2025 | 31.68% |
| 2024 | 6.73% |
| 2023 | 91.06% |
| 2022 | -34.74% |
| 2021 | -21.56% |
| 2020 | -30.26% |
| 2019 | -19.05% |
| 2018 | 267.23% |
| 2017 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $534.12 | 25.25% |
US
|
|
| $231.12 | 760.78% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $880.75 | 8.18% |
NL
|
|
| $289.51 | 1.72% |
BE
|
